Bamboos Health Care Holdings Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wir verfügen derzeit nicht über ausreichende Analystenabdeckung, um Wachstum und Umsatz für Bamboos Health Care Holdings zu prognostizieren.

Wichtige Informationen

n/a

Wachstumsrate der Gewinne

n/a

EPS-Wachstumsrate

Healthcare Gewinnwachstum	22.3%
Wachstumsrate der Einnahmen	n/a
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	None
Zuletzt aktualisiert	n/a

Jüngste Aktualisierungen zum künftigen Wachstum

Keine Aktualisierungen

Recent updates

Shareholders May Not Be So Generous With Bamboos Health Care Holdings Limited's (HKG:2293) CEO Compensation And Here's Why

Nov 22

Some Investors May Be Worried About Bamboos Health Care Holdings' (HKG:2293) Returns On Capital

Aug 20

The Returns On Capital At Bamboos Health Care Holdings (HKG:2293) Don't Inspire Confidence

May 02

Income Investors Should Know That Bamboos Health Care Holdings Limited (HKG:2293) Goes Ex-Dividend Soon

Mar 10

Does Bamboos Health Care Holdings Limited (HKG:2293) Have A Place In Your Dividend Portfolio?

Jan 29

Here's What To Make Of Bamboos Health Care Holdings' (HKG:2293) Returns On Capital

Jan 08

Bamboos Health Care Holdings Limited's (HKG:2293) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Dec 18

We Think Bamboos Health Care Holdings's (HKG:2293) Statutory Profit Might Understate Its Earnings Potential

Nov 27

In diesem Abschnitt stellen wir normalerweise Umsatz- und Gewinnwachstumsprognosen vor, die auf den Konsensschätzungen professioneller Analysten basieren, um den Anlegern zu helfen, die Fähigkeit des Unternehmens zur Gewinnerzielung zu verstehen. Da Bamboos Health Care Holdings jedoch nicht genügend Daten aus der Vergangenheit zur Verfügung gestellt hat und keine Analystenprognose vorliegt, können die zukünftigen Erträge nicht zuverlässig durch Extrapolation von Vergangenheitsdaten oder anhand von Analystenprognosen berechnet werden.

Dies ist eine recht seltene Situation, da 97 % der von SimplyWall St erfassten Unternehmen über Finanzdaten aus der Vergangenheit verfügen.

Gewinn- und Umsatzwachstumsprognosen

SEHK:2293 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (HKD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
6/30/2024	96	31	36	37	N/A
3/31/2024	102	32	36	36	N/A
12/31/2023	109	33	35	36	N/A
9/30/2023	119	40	38	39	N/A
6/30/2023	128	47	42	42	N/A
3/31/2023	132	51	39	47	N/A
12/31/2022	136	56	37	53	N/A
9/30/2022	139	57	69	85	N/A
6/30/2022	141	59	100	116	N/A
3/31/2022	144	67	101	109	N/A
12/31/2021	147	75	102	102	N/A
9/30/2021	129	68	76	76	N/A
6/30/2021	111	61	49	49	N/A
3/31/2021	93	47	45	47	N/A
12/31/2020	76	34	41	44	N/A
9/30/2020	76	32	41	44	N/A
6/30/2020	76	31	42	44	N/A
3/31/2020	79	36	39	41	N/A
12/31/2019	83	40	37	37	N/A
9/30/2019	82	40	34	35	N/A
6/30/2019	82	39	32	32	N/A
3/31/2019	83	38	28	28	N/A
12/31/2018	83	38	24	25	N/A
9/30/2018	84	40	23	24	N/A
6/30/2018	85	42	23	24	N/A
3/31/2018	80	39	N/A	28	N/A
12/31/2017	75	37	N/A	33	N/A
9/30/2017	70	35	N/A	N/A	N/A
6/30/2017	67	33	N/A	34	N/A
3/31/2017	63	31	N/A	N/A	N/A
12/31/2016	58	29	N/A	31	N/A
9/30/2016	57	28	N/A	N/A	N/A
6/30/2016	54	27	N/A	29	N/A
3/31/2016	53	27	N/A	N/A	N/A
12/31/2015	53	26	N/A	26	N/A
9/30/2015	51	24	N/A	N/A	N/A
6/30/2015	49	22	N/A	18	N/A
3/31/2015	47	16	N/A	N/A	N/A
12/31/2014	43	9	N/A	7	N/A
9/30/2014	41	9	N/A	N/A	N/A
6/30/2014	38	9	N/A	16	N/A
3/31/2014	36	12	N/A	N/A	N/A
12/31/2013	34	16	N/A	21	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von 2293 über der Sparquote liegt (2.3%).

Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von 2293 schneller wachsen werden als der Markt Hong Kong

Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von 2293 in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von 2293 schneller wachsen werden als der Markt von Hong Kong.

Hohe Wachstumseinnahmen: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Einnahmen von 2293 schneller wachsen werden als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von 2293 in 3 Jahren voraussichtlich hoch sein wird

Bamboos Health Care Holdings Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Full year 2024 earnings released: EPS: HK$0.077 (vs HK$0.12 in FY 2023)

Full year 2024 earnings released: EPS: HK$0.077 (vs HK$0.12 in FY 2023)

Bamboos Health Care Holdings Limited, Annual General Meeting, Nov 28, 2024

Now 26% undervalued after recent price drop

Be Wary Of Bamboos Health Care Holdings (HKG:2293) And Its Returns On Capital

Bamboos Health Care Holdings Limited to Report Fiscal Year 2024 Results on Sep 26, 2024

Insufficient new directors

CEO & Executive Chairman recently bought HK$389k worth of stock

First half 2024 earnings released: EPS: HK$0.043 (vs HK$0.076 in 1H 2023)

Upcoming dividend of HK$0.05 per share

First half dividend of HK$0.05 announced

Bamboos Health Care Holdings Limited Announces Interim Dividend for the Six Months Ended 31 December 2023, Payable on March 22, 2024

Bamboos Health Care Holdings Limited to Report Q2, 2024 Results on Feb 27, 2024

Upcoming dividend of HK$0.037 per share at 10% yield

Bamboos Health Care Holdings (HKG:2293) Is Reducing Its Dividend To HK$0.0375

Full year 2023 earnings released: EPS: HK$0.12 (vs HK$0.15 in FY 2022)

Full year 2023 earnings released: EPS: HK$0.12 (vs HK$0.15 in FY 2022)

Bamboos Health Care Holdings Limited, Annual General Meeting, Nov 28, 2023

Bamboos Health Care Holdings Limited to Report Fiscal Year 2023 Results on Sep 26, 2023

Upcoming dividend of HK$0.037 per share at 13% yield

First half 2023 earnings released: EPS: HK$0.077 (vs HK$0.084 in 1H 2022)

Bamboos Health Care Holdings Limited to Report First Half, 2023 Results on Feb 23, 2023

Bamboos Health Care Holdings (HKG:2293) Knows How To Allocate Capital

Upcoming dividend of HK$0.05 per share

CEO & Executive Chairman recently bought HK$130k worth of stock

Bamboos Health Care Holdings Limited, Annual General Meeting, Nov 29, 2022

Full year 2022 earnings released: EPS: HK$0.15 (vs HK$0.15 in FY 2021)

Bamboos Health Care Holdings Limited to Report Fiscal Year 2022 Results on Sep 27, 2022

First half 2022 earnings released: EPS: HK$0.084 (vs HK$0.049 in 1H 2021)

Bamboos Health Care Holdings (HKG:2293) Is Due To Pay A Dividend Of HK$0.025

Upcoming dividend of HK$0.025 per share

Bamboos Health Care Holdings Limited Announces Change of Company Secretary and Authorised Representative

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Bamboos Health Care Holdings (HKG:2293) Has Announced A Dividend Of HK$0.025

Bamboos Health Care Holdings Limited Declares Interim Dividend for the Six Months Ended December 31, 2021, Payable on 25 March 2022

Bamboos Health Care Holdings Limited to Report First Half, 2022 Results on Feb 22, 2022

Shareholders May Not Be So Generous With Bamboos Health Care Holdings Limited's (HKG:2293) CEO Compensation And Here's Why

Inaugural dividend of HK$0.075 per share

Full year 2021 earnings released: EPS HK$0.15 (vs HK$0.077 in FY 2020)

Investor sentiment improved over the past week

High number of new and inexperienced directors

Some Investors May Be Worried About Bamboos Health Care Holdings' (HKG:2293) Returns On Capital

Independent Non-Executive Director Peck Lim Chhoa has left the company

Independent Non-Executive Director Wing Man Ko has left the company

The Returns On Capital At Bamboos Health Care Holdings (HKG:2293) Don't Inspire Confidence

First half 2021 earnings released: EPS HK$0.049 (vs HK$0.042 in 1H 2020)

Bamboos Health Care Holdings Limited Declares Interim Dividend for the Six Months Ended 31 December 2020, Payable on 26 March 2021

Income Investors Should Know That Bamboos Health Care Holdings Limited (HKG:2293) Goes Ex-Dividend Soon

First half 2021 earnings released: EPS HK$0.049 (vs HK$0.042 in 1H 2020)

Bamboos Health Care Holdings Limited to Report First Half, 2021 Results on Feb 23, 2021

New 90-day high: HK$0.88

Does Bamboos Health Care Holdings Limited (HKG:2293) Have A Place In Your Dividend Portfolio?

Here's What To Make Of Bamboos Health Care Holdings' (HKG:2293) Returns On Capital

Bamboos Health Care Holdings Limited's (HKG:2293) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

New 90-day low: HK$0.73

We Think Bamboos Health Care Holdings's (HKG:2293) Statutory Profit Might Understate Its Earnings Potential

New 90-day low: HK$0.90

Upcoming Dividend of HK$0.025 Per Share

Full year earnings released - EPS HK$0.077

Full year earnings released - EPS HK$0.077

Bamboos Health Care Holdings Limited to Report Fiscal Year 2020 Results on Sep 18, 2020

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken